BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 56046)

  • 1. Specificity of immune paralysis at large tumor volumes.
    Pardridge DH; Wang BS; Mannick JA; Deckers PJ
    Surg Forum; 1975; 26():118-20. PubMed ID: 56046
    [No Abstract]   [Full Text] [Related]  

  • 2. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation or inhibition of immune resistance against metastatic or local growth of a C3H mammary carcinoma.
    Vaage J; Agarwal S
    Cancer Res; 1976 May; 36(5):1831-6. PubMed ID: 1268839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage processing of antigen for induction of tumor immunity.
    Brunda MJ; Raffel S
    Cancer Res; 1977 Jun; 37(6):1838-44. PubMed ID: 66987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for related antigens on sperm, tumor, and fetal cells in the mouse.
    Goldberg EH; Tokuda S
    Transplant Proc; 1977 Jun; 9(2):1363-5. PubMed ID: 878010
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.
    Greene MI; Fujimoto S; Sehon AH
    J Immunol; 1977 Aug; 119(2):757-64. PubMed ID: 69667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic enhancement in a syngeneic tumor system.
    Beltz WR; Levy NL
    Surg Forum; 1975; 26():142-4. PubMed ID: 1216091
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-GuĂ©rin and tumor cells.
    Zbar B; Canti G; Rapp HJ; Ashley MP; Sukumar S; Bast RC
    Cancer Res; 1980 Apr; 40(4):1036-42. PubMed ID: 7357533
    [No Abstract]   [Full Text] [Related]  

  • 15. Protective serum effects in tumor immunity.
    Vaage J
    Isr J Med Sci; 1976; 12(4-5):334-43. PubMed ID: 939693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thymus on autosensitization against syngeneic normal and malignant cells.
    Carnaud C; Ilfeld D; Petranyi G; Klein E
    Eur J Immunol; 1975 Aug; 5(8):575-9. PubMed ID: 1234062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic enhancement induced by antibody fragments.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased tumour growth after blood transfusion.
    Clarke PJ; Wood KJ; Morris PJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):584-5. PubMed ID: 2705237
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF; Snell GD
    Transplant Proc; 1973 Mar; 5(1):953-6. PubMed ID: 4572155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.